{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:05:51Z","timestamp":1770422751364,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jsps.2023.101801","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T15:44:06Z","timestamp":1695743046000},"page":"101801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Probable rivaroxaban-induced erythema multiforme in children: A case report"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1703-5161","authenticated-orcid":false,"given":"Zhongqiang","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengran","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoya","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0048-2658","authenticated-orcid":false,"given":"Xiaoling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2023.101801_b0005","first-page":"181","article-title":"Anti-Xa inhibitor-induced hemorrhagic pruritic rash: a case report on possible cross-reactivity between apixaban and rivaroxaban","volume":"13","author":"Anis","year":"2021","journal-title":"Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.jsps.2023.101801_b0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.anai.2016.03.012","article-title":"Rivaroxaban-induced leukocytoclastic vasculitis: a challenging rash","volume":"116","author":"Chaaya","year":"2016","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"4","key":"10.1016\/j.jsps.2023.101801_b0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2174\/1381612827666211111150705","article-title":"Anticoagulation treatment in venous thromboembolism: options and optimal duration","volume":"28","author":"Diavati","year":"2022","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.jsps.2023.101801_b0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/dth.15051","article-title":"Rivaroxaban for treatment of livedoid vasculopathy: a systematic review","volume":"34","author":"Gao","year":"2021","journal-title":"Dermatol. Ther."},{"issue":"2","key":"10.1016\/j.jsps.2023.101801_b0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.jsps.2023.101801_b0030","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.12260","article-title":"Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs","volume":"68","author":"Kowalski","year":"2013","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.jsps.2023.101801_b0035","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0883073812463607","article-title":"Aspirin use in Sturge-Weber syndrome: side effects and clinical outcomes","volume":"28","author":"Lance","year":"2013","journal-title":"J. Child Neurol."},{"issue":"7","key":"10.1016\/j.jsps.2023.101801_b0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ajhp\/zxac387","article-title":"Just DOAC: use of direct-acting oral anticoagulants in pediatrics","volume":"80","author":"Mills","year":"2023","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"2","key":"10.1016\/j.jsps.2023.101801_b0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.jsps.2023.101801_b0050","first-page":"347","article-title":"Rash associated with rivaroxaban use","volume":"75","author":"Rudd","year":"2018","journal-title":"Bull. Am. Soc. Hospital Pharmacists"},{"issue":"9921","key":"10.1016\/j.jsps.2023.101801_b0055","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jsps.2023.101801_b0060","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/0897190017722872","article-title":"Probable rivaroxaban-induced full body rash: a case report","volume":"31","author":"Sasson","year":"2018","journal-title":"J. Pharm. Pract."},{"issue":"2","key":"10.1016\/j.jsps.2023.101801_b0065","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11239-013-0991-z","article-title":"Structure-function relationships of factor Xa inhibitors: implications for the practicing clinician","volume":"37","author":"Steinberg","year":"2014","journal-title":"J. Thromb. Thrombolysis"},{"issue":"7","key":"10.1016\/j.jsps.2023.101801_b0070","doi-asserted-by":"crossref","first-page":"1325.e1","DOI":"10.1016\/j.ajem.2015.12.021","article-title":"Hypersensitivity reaction after administration of rivaroxaban (Xarelto)","volume":"34","author":"Vernon","year":"2016","journal-title":"Am. J. Emergency Med."},{"key":"10.1016\/j.jsps.2023.101801_b0075","unstructured":"XARELTO\u00ae (rivaroxaban) tablets [package insert]. Titusville, NJ: Janssen Pharmaceuticals, Inc. 2017."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423002967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016423002967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:28:59Z","timestamp":1736184539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016423002967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1319016423002967"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2023.101801","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probable rivaroxaban-induced erythema multiforme in children: A case report","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2023.101801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}],"article-number":"101801"}}